Impaired catabolism of branched-chain amino acids—modulated by pathogenic variants in BCKDHA and loss-of-function alleles in PPM1K—compromises tissue-selective disposal of these metabolites, thereby fostering insulin resistance and accelerating the progression of type 2 diabetes mellitus (30). The gene discussed is INS; the disease is diabetes mellitus.